| Title : Therapeutic potential of [(177)Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment - Yadav_2024_Eur.J.Nucl.Med.Mol.Imaging_51_805 |
| Author(s) : Yadav MP , Ballal S , Martin M , Roesch F , Satapathy S , Moon ES , Tripathi M , Gogia A , Bal C |
| Ref : Eur J Nucl Med Mol Imaging , 51 :805 , 2024 |
| Abstract : |
| PubMedSearch : Yadav_2024_Eur.J.Nucl.Med.Mol.Imaging_51_805 |
| PubMedID: 37932560 |
| Title : Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the (68)Ga- and (177)Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)(2) - Lappchen_2024_Molecules_29_ |
| Author(s) : Lappchen T , Bilinska A , Pilatis E , Menendez E , Imlimthan S , Moon ES , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
| Ref : Molecules , 29 : , 2024 |
| Abstract : |
| PubMedSearch : Lappchen_2024_Molecules_29_ |
| PubMedID: 38999044 |
| Title : Next generation fibroblast activation protein (FAP) targeting PET tracers - The tetrazine ligation allows an easy and convenient way to (18)F-labeled (4-quinolinoyl)glycyl-2-cyanopyrrolidines - Poulie_2023_Eur.J.Med.Chem_262_115862 |
| Author(s) : Poulie CBM , Shalgunov V , Elvas F , Van Rymenant Y , Moon ES , Battisti UM , De Loose J , De Meester I , Rosch F , Van der Veken P , Herth MM |
| Ref : Eur Journal of Medicinal Chemistry , 262 :115862 , 2023 |
| Abstract : |
| PubMedSearch : Poulie_2023_Eur.J.Med.Chem_262_115862 |
| PubMedID: 37883899 |
| Title : Head-to-Head Comparison between [(68)Ga]Ga-DOTA.SA.FAPi and [(18)F]F-FDG PET\/CT Imaging in Patients with Breast Cancer - Ballal_2023_Pharmaceuticals.(Basel)_16_ |
| Author(s) : Ballal S , Yadav MP , Roesch F , Wakade N , Raju S , Sheokand P , Mishra P , Moon ES , Tripathi M , Martin M , Bal C |
| Ref : Pharmaceuticals (Basel) , 16 : , 2023 |
| Abstract : |
| PubMedSearch : Ballal_2023_Pharmaceuticals.(Basel)_16_ |
| PubMedID: 37111277 |
| Title : Translational assessment of a DATA-functionalized FAP inhibitor with facile (68)Ga-labeling at room temperature - Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202 |
| Author(s) : Escudero-Castellanos A , Kurth J , Imlimthan S , Menendez E , Pilatis E , Moon ES , Lappchen T , Rathke H , Schwarzenbock SM , Krause BJ , Rosch F , Rominger A , Gourni E |
| Ref : Eur J Nucl Med Mol Imaging , 50 :3202 , 2023 |
| Abstract : |
| PubMedSearch : Escudero-Castellanos_2023_Eur.J.Nucl.Med.Mol.Imaging_50_3202 |
| PubMedID: 37284857 |
| Title : Fibroblast Activation Protein (FAP) targeting homodimeric FAP inhibitor radiotheranostics: a step to improve tumor uptake and retention time - Moon_2021_Am.J.Nucl.Med.Mol.Imaging_11_476 |
| Author(s) : Moon ES , Ballal S , Yadav MP , Bal C , Van Rymenant Y , Stephan S , Bracke A , Van der Veken P , De Meester I , Roesch F |
| Ref : Am J Nucl Med Mol Imaging , 11 :476 , 2021 |
| Abstract : |
| PubMedSearch : Moon_2021_Am.J.Nucl.Med.Mol.Imaging_11_476 |
| PubMedID: 35003886 |
| Title : Biodistribution, pharmacokinetics, dosimetry of [(68)Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [(18)F]F-FDG PET\/CT in patients with various cancers - Ballal_2021_Eur.J.Nucl.Med.Mol.Imaging_48_1915 |
| Author(s) : Ballal S , Yadav MP , Moon ES , Kramer VS , Roesch F , Kumari S , Tripathi M , ArunRaj ST , Sarswat S , Bal C |
| Ref : Eur J Nucl Med Mol Imaging , 48 :1915 , 2021 |
| Abstract : |
| PubMedSearch : Ballal_2021_Eur.J.Nucl.Med.Mol.Imaging_48_1915 |
| PubMedID: 33244617 |
| Title : New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress - Imlimthan_2021_Pharmaceuticals.(Basel)_14_ |
| Author(s) : Imlimthan S , Moon ES , Rathke H , Afshar-Oromieh A , Rosch F , Rominger A , Gourni E |
| Ref : Pharmaceuticals (Basel) , 14 : , 2021 |
| Abstract : |
| PubMedSearch : Imlimthan_2021_Pharmaceuticals.(Basel)_14_ |
| PubMedID: 34681246 |
| Gene_locus related to this paper: human-FAP |
| Title : Fibroblast activation protein inhibitor (FAPi) positive tumour fraction on PET\/CT correlates with Ki-67 in liver metastases of neuroendocrine tumours - Kreppel_2021_Nuklearmedizin_60_344 |
| Author(s) : Kreppel B , Gonzalez-Carmona MA , Feldmann G , Kuppers J , Moon ES , Marinova M , Bundschuh RA , Kristiansen G , Essler M , Roesch F , Gaertner FC |
| Ref : Nuklearmedizin , 60 :344 , 2021 |
| Abstract : |
| PubMedSearch : Kreppel_2021_Nuklearmedizin_60_344 |
| PubMedID: 34256394 |
| Title : In Vitro Evaluation of the Squaramide-Conjugated Fibroblast Activation Protein Inhibitor-Based Agents AAZTA(5).SA.FAPi and DOTA.SA.FAPi - Moon_2021_Molecules_26_3482 |
| Author(s) : Moon ES , Van Rymenant Y , Battan S , De Loose J , Bracke A , Van der Veken P , De Meester I , Rosch F |
| Ref : Molecules , 26 :3482 , 2021 |
| Abstract : |
| PubMedSearch : Moon_2021_Molecules_26_3482 |
| PubMedID: 34201111 |
| Gene_locus related to this paper: human-FAP |
| Title : Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA(5m) chelators - Moon_2020_EJNMMI.Radiopharm.Chem_5_19 |
| Author(s) : Moon ES , Elvas F , Vliegen G , De Lombaerde S , Vangestel C , De Bruycker S , Bracke A , Eppard E , Greifenstein L , Klasen B , Kramer V , Staelens S , De Meester I , Van der Veken P , Rosch F |
| Ref : EJNMMI Radiopharm Chem , 5 :19 , 2020 |
| Abstract : |
| PubMedSearch : Moon_2020_EJNMMI.Radiopharm.Chem_5_19 |
| PubMedID: 32728930 |